IPO Update: Mineralys Therapeutics Readies $150 Million IPO Plan [Seeking Alpha]
Impel Pharmaceuticals Inc. (IMPL)
Company Research
Source: Seeking Alpha
SolskinA Quick Take On Mineralys TherapeuticsMineralys Therapeutics (MLYSThe firm is a clinical-stage biopharma developing treatments for diseasesdue to abnormally elevated aldosterone.MLYS has produced positive Phase 2 efficacy results for its primary candidate.Given the firm's positive efficacy results so far, it's backing by well-known venture capital firm investors and it's relatively short time to a potential upside catalyst, for life science investors with an 18- to 24-month hold time frame, my outlook is a Buy at up to $15.00 per share.Mineralys OverviewRadnor, Pennsylvania-based Mineralys Therapeutics was founded to develop lorundrostat, an aldosterone inhibitor that promises to reduce uncontrolled hypertension [uHTN] in patients unable to achieve blood pressure below 130/80.Management is headed byChief Executive Officer Jon Congleton, who has been with the firm since November 2020 and was previously CEO of Impel NeuroPharma and before that, CEO of Nivalis Therapeutics.The fir
Show less
Read more
Impact Snapshot
Event Time:
IMPL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IMPL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IMPL alerts
High impacting Impel Pharmaceuticals Inc. news events
Weekly update
A roundup of the hottest topics